alanine has been researched along with prazosin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, H; Kobayashi, M; Ohinata, M; Ohori, M; Shiraiwa, Y; Tsuzuki, T; Yamaguchi, O; Yokota, T | 1 |
Naidu, KA; Radhakrishnamurty, R | 1 |
Dey, S; Gottesman, MM; Hafkemeyer, P; Pastan, I | 1 |
Epstein, CJ; Gray, MO; Honbo, N; Karliner, JS; Lau, YF; Xian, M | 1 |
Ahmed, M; Bhuiyan, MA; Hossain, M; Nagatomo, T; Ohnuki, T; Takahashi, K | 1 |
Andersson, Å; Lewis, RJ; Ragnarsson, L; Thomas, WG | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
1 trial(s) available for alanine and prazosin
Article | Year |
---|---|
Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
Topics: Aged; Aged, 80 and over; Alanine; Double-Blind Method; Drug Combinations; Glutamates; Glycine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prazosin; Prostatic Hyperplasia; Urethral Obstruction; Urodynamics | 1990 |
6 other study(ies) available for alanine and prazosin
Article | Year |
---|---|
Effect of metalaxyl on heart rate in rats: role of alpha 1-adrenoreceptors.
Topics: Alanine; Animals; Depression, Chemical; Heart Rate; Injections, Intraperitoneal; Male; Phentolamine; Prazosin; Random Allocation; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1989 |
A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.
Topics: Adenosine Triphosphate; Alanine; Amino Acid Substitution; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Dopamine Antagonists; Flupenthixol; HeLa Cells; Humans; Hydrolysis; Iodine Radioisotopes; Mutagenesis, Site-Directed; Phenylalanine; Photoaffinity Labels; Prazosin; Receptors, Dopamine; Stereoisomerism; Substrate Specificity; Tumor Cells, Cultured; Verapamil | 1999 |
Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase.
Topics: Adrenergic alpha-Antagonists; Alanine; Animals; Animals, Newborn; Bromodeoxyuridine; Cardiotonic Agents; Cell Survival; Cells, Cultured; Cytarabine; Female; Fibroblasts; Flow Cytometry; Gene Deletion; Humans; Hypoxia; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Transgenic; Myocardium; Norepinephrine; Oxidative Stress; Phenylephrine; Prazosin; Recombinant Fusion Proteins; Superoxide Dismutase; Time Factors; Transgenes; Vasoconstrictor Agents | 2000 |
Asp125 and Thr130 in transmembrane domain 3 are major sites of alpha1b-adrenergic receptor antagonist binding.
Topics: Adrenergic alpha-Antagonists; Alanine; Aspartic Acid; Binding, Competitive; Blotting, Western; Cells, Cultured; DNA, Complementary; Humans; Hydrolysis; Ligands; Models, Molecular; Phosphatidylinositols; Prazosin; Receptors, Adrenergic, alpha-1; Threonine; Transfection | 2007 |
Extracellular surface residues of the α1B-adrenoceptor critical for G protein-coupled receptor function.
Topics: Adrenergic alpha-1 Receptor Antagonists; Alanine; Animals; Binding Sites; Cricetinae; Models, Molecular; Molecular Conformation; Mutagenesis; Norepinephrine; Polymorphism, Single Nucleotide; Prazosin; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Adrenergic, alpha-1; Receptors, G-Protein-Coupled | 2015 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |